Parabilis Medicines, Inc (PBLS) insider trading

Every open-market stock purchase and sale by Parabilis Medicines, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders bought $434M over the last 12 months (4 buys).
  • Last insider buy: Alan Sebulsky (Insider), $130K, 4 months ago.

Last 12 months: insiders bought $434M (4 buys) and sold $0 (0 sales).

Recent PBLS insider trades

DateInsiderTradeValue
Jun 15, 2026Alan Sebulsky (Insider)Bought$130K
Jun 15, 2026Alan Sebulsky (Insider)Bought$110K
Jun 12, 2026Alan Sebulsky (Insider)Bought$233K
Jun 11, 2026Ra Capital Management L.p. (Insider)Bought$395M
Jun 11, 2026Ra Capital Management L.p. (Insider)Bought$29.2M
Jun 11, 2026Guy Levy (10% owner)Bought$7.5M
Jun 11, 2026Guy Levy (10% owner)Bought$2.5M
Jun 11, 2026Alan Sebulsky (Insider)Bought$250K
Jun 11, 2026James E Flynn (10% owner)Bought (not open market)—
Jun 11, 2026Alexis Borisy (Insider)Bought (not open market)—
Jun 11, 2026Edward M Fitzgerald (Insider)Bought (not open market)—
Jun 11, 2026Edward M Fitzgerald (Insider)Bought (not open market)—
Jun 11, 2026Edward M Fitzgerald (Insider)Bought (not open market)—
Jun 11, 2026James E Flynn (10% owner)Bought (not open market)—
Jun 11, 2026Alexis Borisy (Insider)Bought (not open market)—
Jun 11, 2026James E Flynn (10% owner)Bought (not open market)—
Jun 11, 2026James E Flynn (10% owner)Bought (not open market)—
Jun 11, 2026James E Flynn (10% owner)Bought (not open market)—
Jun 11, 2026James E Flynn (10% owner)Bought (not open market)—
Jun 11, 2026Edward M Fitzgerald (Insider)Bought (not open market)—
Jun 11, 2026Edward M Fitzgerald (Insider)Bought (not open market)—
Jun 11, 2026Edward M Fitzgerald (Insider)Bought (not open market)—
Jun 11, 2026Ra Capital Management L.p. (Insider)Bought (not open market)—
Jun 11, 2026Ra Capital Management L.p. (Insider)Bought (not open market)—
Jun 11, 2026Ra Capital Management L.p. (Insider)Bought (not open market)—

Who's trading PBLS

Get free alerts when an insider at Parabilis Medicines, Inc files a new trade →